Expressiona and Diagnostic Potential of miRNAs in NSCLC

NCT05815407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-04-18

No results posted yet for this study

Summary

Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients

Conditions

  • Non Small Cell Lung Cancer

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • National Cancer Institute, Cairo University, Egypt

    collaborator UNKNOWN
  • Al-Azhar University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05815407 on ClinicalTrials.gov